Innocan Company
InnoCan Pharma announced a collaboration with Tel Aviv University to instill CBD medicine through exosomes — or the small cell structures created when stem cells multiply. The unconventional method will utilize the exosomes as “homing missiles,” as they can uniquely target cell organs damaged by COVID-19. Researchers then believe CBD’s anti-inflammatory properties will repair the damaged cells through a synergistic effect.
Technology:
COVID
Industry:
Treatments
Headquarters:
Israel
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership